One-year outcomes of the U. S

Slides:

Advertisements

Similar presentations

Surgical outcomes of vascular reconstruction in soft tissue sarcomas of the lower extremities Kenji Nishinari, MD, PhD, Mariana Krutman, MD, Samuel Aguiar.

Advertisements

Society for Vascular Surgery (SVS) Vascular Registry evaluation of comparative effectiveness of carotid revascularization procedures stratified by Medicare.

Duplex Ultrasound Criteria for Renal Artery In-Stent Restenosis

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Primary stenting of femoropopliteal atherosclerotic lesions using new helical interwoven nitinol stents Yiu Che Chan, MBBS, BSc, MD, FRCS, Stephen W.

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Incidence, predictors, and prognosis of in-stent occlusion after endovascular treatment with nitinol stents for femoropopliteal lesions Tomoharu Dohi,

Stenting of femoropopliteal lesions using interwoven nitinol stents

Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease

Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required Brian Tiu, MD, Michael Shih,

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions Andrew M. Bakken, MD, Eugene Palchik, MD, Joseph P. Hart,

Altered in-stent hemodynamics may cause erroneous upgrading of moderate carotid artery restenosis when evaluated by duplex ultrasound Maani Hakimi, MD,

Adjunctive use of the superficial femoral vein for vascular reconstructions Soma Brahmanandam, MD, MPH, Daniel Clair, MD, James Bena, MS, Timur Sarac,

Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions Takao Ohki, MD, PhD, Kimihiko.

A randomized phase II study of Xilonix, a targeted therapy against interleukin 1α, for the prevention of superficial femoral artery restenosis after percutaneous.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Application of duplex ultrasound imaging in determining in-stent stenosis during surveillance after mesenteric artery revascularization Aaron C. Baker,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Duplex ultrasound criteria for femorofemoral bypass revision

Michael J. Singh, MD, Ronald Fairman, MD, Paul Anain, MD, William D

Early duplex scanning after infrainguinal endovascular therapy

Use of a proactive duplex ultrasound protocol for hemodialysis access

Statin therapy is associated with superior clinical outcomes after endovascular treatment of critical limb ischemia Francesco A. Aiello, MD, Asad A.

Bernardino C. Branco, MD, Mina L. Boutrous, MD, Joseph J

Ahsan T. Ali, MD, Mario Rueda, MD, Sarasijhaa Desikan, MD, Mohammed M

Mesenteric stenting for chronic mesenteric ischemia

Evolving treatment of popliteal artery aneurysms

Late outcomes of balloon angioplasty and angioplasty with selective stenting for superficial femoral-popliteal disease are equivalent Bao-Ngoc Nguyen,

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Christopher J. Smolock, MD, Javier E

Michael C. Soult, MD, Joseph C. Wuamett, MD, S

Percutaneous intervention for infrainguinal occlusive disease in women: Equivalent outcomes despite increased severity of disease compared with men Brian.

Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery.

The number of patent tibial vessels does not influence primary patency after nitinol stenting of the femoral and popliteal arteries Jenny J. Lee, MD,

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions Gautam V. Shrikhande, MD,

Thomas S. Huber, MD, PhD, Michael P. Brown, DO, James M. Seeger, MD, W

Jesse A. Columbo, MD, Bjoern D. Suckow, MD, MS, Claire L

Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions Osamu Iida, MD, Shinsuke Nanto, MD, Masaaki Uematsu,

Utility of new classification based on clinical and lesional factors after self-expandable nitinol stenting in the superficial femoral artery Yoshimitsu.

Dual antiplatelet therapy (clopidogrel and aspirin) is associated with increased all-cause mortality after carotid revascularization for asymptomatic.

Thomas A. Simone, MD, Benjamin S. Brooke, MD, PhD, Philip P

The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé.

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Outcome of drug-eluting balloon angioplasty versus endarterectomy in common femoral artery occlusive disease Tzu-Ting Kuo, MD, Po-Lin Chen, MD, Chun-Yang.

Reply Journal of Vascular Surgery

Chung-Dann Kan, MD, Hsin-Ling Lee, MD, Yu-Jen Yang, MD, PhD

Todd R. Vogel, MD, MPH, Robin L. Kruse, PhD

Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive.

Percutaneous intervention for infrageniculate arterial disease in women may be associated with better outcomes when compared to men Andrew Tye, BA, Daniel.

Proposed duplex velocity criteria for carotid restenosis following carotid endarterectomy with patch closure Ali F. AbuRahma, MD, Patrick Stone, MD,

Incidence and clinical significance of distal embolization during percutaneous interventions involving the superficial femoral artery Russell C. Lam,

Rabih A. Chaer, MD, Joel E. Barbato, MD, Stephanie C

Mesenteric/celiac duplex ultrasound interpretation criteria revisited

Society for Vascular Surgery Vascular Registry evaluation of stent cell design on carotid artery stenting outcomes Jeffrey Jim, MD, Brian G. Rubin, MD,

One-Stage Upper Arm Brachial-Basilic Arteriovenous Fistulas Have Superior Patency to Two-Stage Procedure Tze-Woei Tan, MD, Jeffrey Siracuse, MD, Karen.

Correlation of invasive Doppler flow wire with renal duplex ultrasonography in the evaluation of renal artery stenosis: The Renal Artery Stenosis Invasive.

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Sikandar Z. Khan, MD, Muhammad A

Femorofemoral bypass with femoral popliteal vein

Journal of Vascular Surgery

Midterm outcomes of the Zenith Renu AAA Ancillary Graft

True Radial Artery Aneurysm: Diagnosis and Treatment

Ultrasound velocity criteria for renal in-stent restenosis

Patrick A. Stone, MD, Ali F. AbuRahma, MD, Sarah K. Flaherty, BS

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses Caitlin W. Hicks, MD, MS,

Critical analysis of renal duplex ultrasound parameters in detecting significant renal artery stenosis Ali F. AbuRahma, MD, Mohit Srivastava, MD, Albeir.

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Presentation transcript:

One-year outcomes of the U. S One-year outcomes of the U.S. and Japanese regulatory trial of the Misago stent for treatment of superficial femoral artery disease (OSPREY study) Takao Ohki, MD, John F. Angle, MD, Hiroyoshi Yokoi, MD, Michael R. Jaff, DO, Jeffrey Popma, MD, Guy Piegari, MD, Yuji Kanaoka, MD Takao Ohki, MD, PhD, J. Fritz Angle, MD, Andrew Feiring, MD, Brian Nelson, MD, Marc Glickman, MD, Marcelo Guimaraes, MD, Patrick Hall, MD, Sarah Johnson, MD, William Jordan, MD, Omran Khoudoud, MD, Daniel Leung, MD, Joseph McGarvey, MD, James McKinsey, MD, Roman Nowygrod, MD, Nicolas Shammas, MD, Daniel Carey, MD, Srinivas Iyengar, MD, Daniel Isenbarger, MD, Vaqar Ali, MD, Majdi Ashchi, DO, Ernesto Rivera, MD, Mohammed Moursi, MD, William Bachinsky, MD, Christopher Metzger, MD, Guy Piegari, MD, Herbert Aronow, MD, Bret Wiechmann, MD, Christopher Callicutt, MD, Ian Gordon, PhD, MD, Peter Chaille, MD, Andrey Espinoza, MD, Malcolm Foster, MD, Mel Sharafuddin, MD, Rakesh Shah, MD, Frank Bunch, MD, Stuart Harlin, MD, Dr Masashi Iwabuchi, Dr Kenji Ando, Dr Kimihiko Kichikawa, Dr Toshiya Muramatsu, Dr Kazushi Urasawa, Dr Yoshiaki Yokoi, Dr Masaaki Uematsu, Dr Ping-Han Lo, Dr Chi-Hung Huang, Dr Hsien-Li Kao, Prof HwanJun Jae Takao Ohki, MD, John F. Angle, MD, Hiroyoshi Yokoi, MD, Michael R. Jaff, DO, Jeffrey Popma, MD, Guy Piegari, MD, Yuji Kanaoka, MD Takao Ohki, MD, PhD, J. Fritz Angle, MD, Andrew Feiring, MD, Brian Nelson, MD, Marc Glickman, MD, Marcelo Guimaraes, MD, Patrick Hall, MD, Sarah Johnson, MD, William Jordan, MD, Omran Khoudoud, MD, Daniel Leung, MD, Joseph McGarvey, MD, James McKinsey, MD, Roman Nowygrod, MD, Nicolas Shammas, MD, Daniel Carey, MD, Srinivas Iyengar, MD, Daniel Isenbarger, MD, Vaqar Ali, MD, Majdi Ashchi, DO, Ernesto Rivera, MD, Mohammed Moursi, MD, William Bachinsky, MD, Christopher Metzger, MD, Guy Piegari, MD, Herbert Aronow, MD, Bret Wiechmann, MD, Christopher Callicutt, MD, Ian Gordon, PhD, MD, Peter Chaille, MD, Andrey Espinoza, MD, Malcolm Foster, MD, Mel Sharafuddin, MD, Rakesh Shah, MD, Frank Bunch, MD, Stuart Harlin, MD, Dr Masashi Iwabuchi, Dr Kenji Ando, Dr Kimihiko Kichikawa, Dr Toshiya Muramatsu, Dr Kazushi Urasawa, Dr Yoshiaki Yokoi, Dr Masaaki Uematsu, Dr Ping-Han Lo, Dr Chi-Hung Huang, Dr Hsien-Li Kao, Prof HwanJun Jae Journal of Vascular Surgery Volume 63, Issue 2, Pages 370-376.e1 (February 2016) DOI: 10.1016/j.jvs.2015.08.093 Copyright © 2016 The Authors Terms and Conditions

Fig 1 Flow chart of subject accountability. DUS, Duplex ultrasound; PSVR, peak systolic velocity ratio. Journal of Vascular Surgery 2016 63, 370-376.e1DOI: (10.1016/j.jvs.2015.08.093) Copyright © 2016 The Authors Terms and Conditions

Fig 2 Kaplan-Meier primary patency within 12 months. Primary patency was considered lost if the stent occluded, target lesion revascularization (TLR) was met, or peak systolic velocity ratio (PSVR) ≥2.5 m/s was met. CL, Confidence limits. Journal of Vascular Surgery 2016 63, 370-376.e1DOI: (10.1016/j.jvs.2015.08.093) Copyright © 2016 The Authors Terms and Conditions